0001246360-14-003019.txt : 20140626 0001246360-14-003019.hdr.sgml : 20140626 20140619172809 ACCESSION NUMBER: 0001246360-14-003019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140617 FILED AS OF DATE: 20140619 DATE AS OF CHANGE: 20140619 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP CENTRAL INDEX KEY: 0000911326 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 561808663 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33 HAYDEN AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: (781) 357-9900 MAIL ADDRESS: STREET 1: 33 HAYDEN AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: TRIMERIS INC DATE OF NAME CHANGE: 19970516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quart Barry D CENTRAL INDEX KEY: 0001384243 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23155 FILM NUMBER: 14931112 MAIL ADDRESS: STREET 1: C/O INTRABIOTICS PHARMACEUTICALS INC STREET 2: 1009 OAK HILL ROAD, SUITE 201 CITY: LAFAYETTE STATE: CA ZIP: 94549 4 1 form.xml PRIMARY DOCUMENT X0306 4 2014-06-17 false 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001384243 Quart Barry D 33 HAYDEN AVE LEXINGTON MA 02421 true false false false Common Stock 2014-06-17 4 M false 1000 23.95 A 1000 D Common Stock 2014-06-17 4 S false 1000 90 D 0 D Stock Option (Right to Buy) 23.95 2014-06-17 4 M false 1000 0 D 2017-06-27 Common Stock 1000 1000 D The stock option exercise and sale of shares of common stock ("Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 10, 2014. The reporting person previously transferred an option to purchase 2,000 Shares of the original 4,000 granted under this stock option, which transfer was not previously reported as permitted under Rule 16a-12 of the Securities Exchange Act. The stock option granted the reporting person an option to purchase 4,000 Shares. These options vested one-third every year over a three-year period and became exercisable on the following schedule: 33.33% on June 27, 2008, 33.33% on June 27, 2009, 33.33% on June 27, 2010. /s/ Thomas W. Beetham, Attorney-in-Fact 2014-06-19